PHARPharming Group N.V.Jul 30, 2026Q2 2026
Read transcript →Pharming Group N.V. (PHAR) Earnings Call Transcripts
NASDAQ·Healthcare·Biotechnology
$11.30
+4.53%
Mkt Cap $813.95M
PHARPharming Group N.V.Jul 30, 2026PHARPharming Group N.V.May 7, 2026Q1 2026
Read transcript →PHARPharming Group N.V.Nov 6, 2025Q3 2025
Read transcript →PHARPharming Group N.V.Aug 1, 2025Q2 2025
Read transcript →PHARPharming Group N.V.May 9, 2025Q1 2025
Read transcript →PHARPharming Group N.V.Mar 13, 2025Q4 2024
Read transcript →PHARPharming Group N.V.Oct 24, 2024Q3 2024
Read transcript →PHARPharming Group N.V.Aug 2, 2024Q2 2024
Read transcript →PHARPharming Group N.V.May 12, 2024Q1 2024
Read transcript →PHARPharming Group N.V.Mar 14, 2024Q4 2023
Read transcript →PHARPharming Group N.V.Oct 27, 2023Q3 2023
Read transcript →PHARPharming Group N.V.Aug 6, 2023Q2 2023
Read transcript →PHARPharming Group N.V.May 11, 2023Q1 2023
Read transcript →PHARPharming Group N.V.Mar 16, 2023Q4 2022
Read transcript →PHARPharming Group N.V.Oct 29, 2022Q3 2022
Read transcript →PHARPharming Group N.V.May 15, 2022Q1 2022
Read transcript →PHARPharming Group N.V.Oct 29, 2021Q3 2021
Read transcript →PHARPharming Group N.V.Aug 8, 2021Q2 2021
Read transcript →PHARPharming Group N.V.Jul 28, 2019Q2 2019
Read transcript →